Charm Therapeutics raised €47M in a Series A round in Jun 2022. The company is based in London, UK. Investors in the round: Axial, Braavos Capital, F-Prime Capital and 3 others. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
